Atlas Trials

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Brain Cancers

Clinical trial NCT00002752 · COMPLETED

Trial details

NCT number
NCT00002752
Sponsor
Duke University
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Brain and Central Nervous System TumorsMetastatic Cancer
Start date
1993-02-01
Primary completion
2003-01-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.